DermaSensor
Overview
DermaSensor Inc. is a Miami-based connected medical device company dedicated to empowering healthcare professionals with clinically proven solutions for efficient skin cancer detection. It provides immediate, objective results to assist non-dermatologist physicians, primarily primary care physicians (PCPs), in making informed referral decisions for lesions suggestive of melanoma, basal cell carcinoma, and squamous cell carcinoma. The device aims to improve early detection rates, increase access to vital healthcare, and ultimately save lives by providing objective data beyond what is visible to the naked eye.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered skin cancer detection
- Elastic Scattering Spectroscopy (ESS) technology
- Non-invasive, handheld device
- Real-time, objective results ('Investigate Further' or 'Monitor')
- 96% sensitivity for detecting melanoma, basal cell carcinoma, and squamous cell carcinoma
- Wireless and ergonomically designed
- Cloud integration for data storage
- Automatic software updates
- Reimbursement assistance available
- Physician finder to locate clinics using DermaSensor
Use Cases
- Assisting primary care physicians (PCPs) in evaluating suspicious skin lesions
- Improving early detection of melanoma, basal cell carcinoma, and squamous cell carcinoma
- Supporting referral decisions to dermatologists
- Enhancing clinical confidence in skin cancer detection
- Streamlining skin cancer assessment workflow in clinical settings
- Providing objective data beyond visual assessment
What Physicians Need to Know
DermaSensor is intended for use by physicians who are not dermatologists, in patients aged 40 and above, to assist in the decision to refer patients to a dermatologist for lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma. It should be used as an adjunctive tool in conjunction with a complete clinical assessment, including visual analysis of the lesion, and not as a standalone diagnostic or screening tool. The device provides a 'Monitor' or 'Investigate Further' result; 'Investigate Further' results include a spectral score from 1 to 10, with higher scores indicating a greater similarity to malignant characteristics. A 'Monitor' result has a high negative predictive value, meaning a low chance of being a false negative. For optimal use, ensure the device tip is placed perpendicularly on the lesion with slight indentation. The device requires calibration once per patient before use.
DermaSensor is designed to integrate into existing clinical workflows with minimal disruption. It is a standalone handheld device that provides immediate results at the point of care. While it generates a Device Result Report that can be saved to a patient's medical record, direct electronic medical record (EMR) integration details are not specified beyond saving a PDF. The company offers dedicated practice implementation support to assist with workflow integration.
Details
| Category | Clinical Decision Support & Reference, Dermatology AI |
| Pricing | Monthly rental basis, with introductory pricing tiers. |
| Deployment | Device |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Dermatology, Family Medicine, Internal Medicine |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-01-12 | DEN230008 De Novo | DermaSensor |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate DermaSensor
Videos
Product demos, reviews, and walkthroughs for DermaSensor.
Introducing DermaSensor
DermaSensor



